Understanding KZIA stock ratios for better investment decisions

Currently, Kazia Therapeutics Limited ADR’s (KZIA) stock is trading at $0.36, marking a gain of 2.51% from last night’s close. At this price, the stock is -78.64% below its 52-week high of $1.68 and 20.65% above its 52-week low of $0.30. Based on the past 30-day period, the stock price is -22.92% below the high and +24.41% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, KZIA’s SMA-200 is $0.8944.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


KZIA’s price to book ratio for the most recent quarter was 1.02, resulting in an 2.43 price to cash per share for the period.

How does Kazia Therapeutics Limited ADR (KZIA) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.

Kazia Therapeutics Limited ADR (NASDAQ: KZIA) Ownership Details

I will give a breakdown of the key shareholders in Kazia Therapeutics Limited ADR (KZIA). Recent figures show that the company’s insiders hold 0.00% of shares. A total of 13 institutional investors hold shares in the company, making 0.92% of its stock and 0.92% of its float.

Sep 29, 2023, it was reported that the Company’s largest institutional holder is Morgan Stanley holding total of 0.19 million shares that make 0.80% of the company’s total number of shares and are currently priced at 66482.0.

The securities firm Acadian Asset Management. LLC holds 18682.0 shares of KZIA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.08%, and the holding percentage of shares is valued at 6538.0.

An overview of Kazia Therapeutics Limited ADR’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Kazia Therapeutics Limited ADR (KZIA) traded 158,961 shares per day, with a moving average of $0.3776 and price change of -0.0600. With the moving average of $0.4745 and a price change of -0.2700, about 106,386 shares changed hands on average over the past 50 days. Finally, KZIA’s 100-day average volume is 92,534 shares, alongside a moving average of $0.6463 and a price change of -0.5300.

Related Posts